ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "PGM1-CDG: isoforms, phenotyping and gene therapy"
Episode Synopsis
Dr Silvia Radenkovic, Professor Eva Morava and Professor Kent Lai join the podcast to discuss recent insights that may enable prognostication in PGM1-CDG, and a promising gene therapy study that could address the cardiomyopathy that remains untreated by Galactose therapy.
The role of PGM1 isoform 2 in PGM1-CDG: One step closer to genotype–phenotype correlation?
Silvia Radenkovic, et al
https://doi.org/10.1002/jimd.12601
Interested listeners may want to read gene therapy paper discussed herein:
https://doi.org/10.1016/j.trsl.2023.01.004
The role of PGM1 isoform 2 in PGM1-CDG: One step closer to genotype–phenotype correlation?
Silvia Radenkovic, et al
https://doi.org/10.1002/jimd.12601
Interested listeners may want to read gene therapy paper discussed herein:
https://doi.org/10.1016/j.trsl.2023.01.004
More episodes of the podcast JIMD Podcasts
Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants
30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff
23/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders
25/11/2025
IMD Research Round-Up: Mitochondrial disease
11/11/2025
In God we trust